Healthcare

Orthocell Limited (ASX:OCC) reports increasing use of Remplir™ during prostate cancer surgery, with approximately 100 procedures completed nationwide. The product is being adopted in nerve-sparing robotic-assisted radical prostatectomy (RARP) as surgeons investigate its potential role in supporting postoperative erectile function and urinary continence.

Pro Medicus Limited (ASX:PME) announced that its U.S. subsidiary, Visage Imaging, Inc., has entered a five-year contract valued at AUD 44M with Advanced Radiology Management, LLC. The agreement centres on the deployment of the Visage 7 Enterprise Imaging Platform, including the Visage 7 Viewer, …

Paradigm Biopharmaceuticals Ltd. (ASX:PAR) has completed the drawdown of Tranche 2, valued at USD 5m (approximately AUD 7.64m), under its USD 27m (AUD 41.2m) Convertible Note Facility with Obsidian Global Partners, LLC. This drawdown is intended to provide additional working capital for the Company’s …

Bio-Gene Technology Limited (ASX:BGT), an Australian developer of natural insecticides, announced that its product Qcide® has been evaluated by the Organic Materials Review Institute (OMRI) in the USA and listed as a Botanical Insecticide under the USDA National Organic Program (USDA NOP).

ReNerve Limited (ASX:RNV) announced that its NervAlign® Nerve Cuff has received approval for use within the US Department of Defense (DoD) and Veterans Affairs (VA) healthcare networks. The development marks a significant step for the company’s nerve repair technology designed for peripheral nerve injury …

Optiscan Imaging Ltd (ASX:OIL) has entered into a three-year Strategic Collaboration Agreement with Australian Clinical Labs Ltd (ASX:ACL) to support the development, validation and deployment of the Company’s InForm digital pathology platform. The agreement is positioned to expand the use of real-time digital pathology …

Medibank Private Limited (ASX:MPL) has entered into an agreement to acquireBetter Medical, a network of 61 general practice and medical clinics across Victoria, Queensland, South Australia, and Tasmania. The transaction, valued at approximately AUD 159 million, will be completed withprivate equityfirmLivingbridgeand other minority shareholders, …